FINWIRES · TerminalLIVE
FINWIRES

那斯達克和標普500指數連續創下歷史新高

-- 週四,隨著人們對中東衝突有望得到解決的希望日益增強,那斯達克指數和標普500指數均創下新高。 那斯達克指數上漲0.4%,收24,102.7點;標普500指數上漲0.3%,收在7,041.3點,兩大指數均連續第二天創下收盤新高。那斯達克指數的連漲勢頭已延續至12個交易日。 道瓊工業指數上漲0.2%,收在48,578.7點。 多數板塊收漲,能源板塊領漲,而醫療保健板塊跌幅最大。 美國總統川普週四表示,黎巴嫩和以色列已同意停火10天。 川普在社群媒體上發文稱,他將邀請以色列總理內塔尼亞胡和黎巴嫩總統奧恩前往白宮進行「有意義的會談」。 「雙方都希望實現和平,我相信和平很快就會到來,」他寫道。 停火旨在暫停以色列與伊朗支持的黎巴嫩真主黨之間的敵對行動,這是美國與德黑蘭和平談判的關鍵癥結所在。 週四下午晚些時候,西德州中質原油價格上漲2.4%,至每桶93.50美元;布蘭特原油價格上漲3.4%,至每桶98.19美元。 「由於市場對霍爾木茲海峽的混亂局面能否很快緩解存在疑慮,油價上漲,」D.A. Davidson在一份報告中表示。 美國公債殖利率走高,10年期公債殖利率上漲2.6個基點至4.31%,2年期公債殖利率上漲1.6個基點至3.79%。 公司新聞方面,IBM(IBM)股價上漲2.5%,成為道瓊指數中漲幅第三大的股票。奧本海默在一份報告中指出,受軟體業務強勁成長以及提前完成對Confluent的收購,這家科技巨頭第一季業績可能超出華爾街預期,並上調營收預期。 IBM計劃於下周公布季度業績。 嘉信理財(SCHW)股價下跌7.6%,標普500指數成分股中跌幅最大。這家金融服務供應商第一季業績年增,客戶資產激增,但營收低於華爾街預期。 雅培(ABT)緊接著嘉信理財之後,在標普500指數中下跌6%。這家醫療保健公司下調了全年獲利預期,以反映對癌症診斷公司Exact Sciences的收購。 百事可樂(PEP)公佈的第一財季業績高於預期,這得益於其推行的降低消費者負擔能力的舉措。這家飲料和零食公司重申了全年業績預期。其股價上漲2.3%。 經濟新聞方面,聯準會數據顯示,美國3月工業生產意外下滑。 牛津經濟研究院在一份報告中指出,現在就將此次下滑歸咎於中東衝突還為時過早,此次下滑主要是由於採礦業和公用事業部門的產出「大幅下降」。 黃金價格最新下跌0.2%,至每盎司4,813.70美元;白銀價格下跌1.2%,至每盎司78.68美元。

Related Articles

Research

Research Alert: CFRA Keeps Buy Opinion On Shares Of The Hartford Insurance Group, Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We trim our 12-month target price by $8 to $155, valuing HIG shares at 11.3x our 2026 operating EPS estimate of $13.75 (cut by $0.45) and at 10.6x our 2027 EPS estimate of $14.65 (cut by $0.30), vs. the shares' one-year average forward multiple of 10.3x and peer average of 13x. Q1 EPS of $3.09 vs. $2.20 a year ago missed our $3.60 estimate and $3.39 consensus view. Operating revenue growth of 6.2% was in line with our 6%-10% forecast, amid 5.3% earned premium growth, 13% higher net investment income, and 7.9% fee revenue growth. Q1 written premium growth of 4% and full-year 2025 growth of 7% bode well for 2026 revenue trends as premiums are earned. Underwriting results improved significantly, with Personal Lines combined ratio improving to 87.7% from 106.1% and underlying combined ratio to 85.0% from 89.7%. Business Insurance combined ratio was stable at 94.8%. Weighing the Q1 EPS miss with HIG's decent top-line growth and discounted valuation to peers, we view the shares as undervalued.

$HIG
Research

Research Alert: CFRA Keeps Strong Buy Opinion On Shares Of Baker Hughes

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We raise our 12-month target price by $14 to $82, reflecting a combination of our sum-of-the-parts (SOTP) and DCF models. For our SOTP model, we presume the oilfield services business (about 50% of BKR's franchise) to be valued at about 10x projected 2027 EBITDA (in line with major peers) and its industrial energy technology business (the other 50%) valued at 14x projected 2027 EBITDA (in line with the peer median). This blended approach, yielding a 12x multiple, implies a value of $73 per share. Meanwhile, our DCF model, using medium-term free cash flow growth of 5% per year, terminal growth of 2.5%, discounted at a WACC of 6.3%, yields intrinsic value of $91 per share. We cut our 2026 EPS estimate by $0.47 to $2.48, but we raise 2027's by $0.07 to $3.24. We acknowledge that the oilfield services business is likely to struggle in 2026 owing to the U.S.-Iran conflict, but the IET business appears quite robust and likely to be a source of both accelerating revenue growth and margins.

$BKR
Research

Research Alert: CFRA Maintains Hold Opinion In Shares Of Wab

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lift our 12-month target to $285 from $275 following WAB's Q1 earnings print, valuing shares at 24.2x our 2027 EPS outlook of $11.76 (revised from $11.46; 2026 EPS estimate up to $10.57 from $10.50), a slight premium to WAB's long-term historical multiple average given structural improvements in earnings quality. While we are cautious on signs of overcapacity in the freight market, an elevated order backlog (12-month sits at over $9 billion), internal initiatives to shore up margins, and potential synergies from M&A activity positions WAB to continue growing earnings at double-digit rates in 2026-2027, in our view. Despite tariff-related cost pressures, WAB has done a commendable job of defending margins via a mix of pricing, lean manufacturing, and pruning of lower-profit operations. Q1 results were mixed but overall positive, in our view. We maintain our Hold recommendation on shares.

$WAB